Fluoroquinolone resistance during 2000–2005 : An observational study

BACKGROUND: Moxifloxacin is a respiratory fluoroquinolone with a community acquired pneumonia indication. Unlike other fluoroquinolones used in our healthcare system, moxifloxacin's urinary excretion is low and thus we hypothesized that increased use of moxifloxacin is associated with an increa...

Descripción completa

Detalles Bibliográficos
Autores principales: Ryan, Richard J, Lindsell, Chris, Sheehan, Paul
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2424048/
https://www.ncbi.nlm.nih.gov/pubmed/18501015
http://dx.doi.org/10.1186/1471-2334-8-71

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2424048/
https://www.ncbi.nlm.nih.gov/pubmed/18501015
http://dx.doi.org/10.1186/1471-2334-8-71

Ejemplares similares